Designing a Pharmacokinetic Machine Learning Model for Optimizing Beta-Lactam Antimicrobial Dosing in Critically Ill Patients
Open Access
- 17 May 2024
- conference paper
- Published by Association for Computing Machinery (ACM)
- p. 311-317
Abstract
In the intensive care unit (ICU), accurate dosing of antimicrobials is crucial to not only benefit the patient but also society by reducing the burden of antimicrobial resistance, considered a major global health threat. Piperacillin-tazobactam (TZP) and meropenem (MEM), two beta-lactam antimicrobials, are frequently prescribed in ICUs worldwide. Current dosing of these antimicrobials has been shown to not reach therapeutic plasma concentrations in many patients. Furthermore, it is believed that appropriate antimicrobial dosing decreases patient morbidity, decreases mortality, and avoids drug toxicity. Therapeutic drug monitoring guided dosing is advocated to optimize the usage of these antimicrobials. However, adoption in clinical practice is limited due to its time-consuming and costly nature. We, therefore, propose a hybrid machine-learning model that incorporates pharmacokinetics into a Catboost regressor model for personalized dosing of TZP and MEM in ICU patients. The resulting model is a single model for both antimicrobials that learns the patient’s drug clearance rate for determining their plasma concentrations and suggesting doses. The model was trained and temporally validated on two different datasets from different periods at the Ghent University Hospital ICU each with|without having access to a previous plasma concentration. The model reached R2 test scores of 0.869|0.807 on the internal dataset and 0.727|0.752 on the time validation dataset. This work established the feasibility of predicting plasma concentrations for an antibiotic group enabling personalized antimicrobial therapy in critically ill patients using machine learning. As such this work contributes to facilitating truly personalized antimicrobial therapy for critically ill patients.Keywords
Funding Information
- Research Foundation Flanders (1S59522N)
- FWO (G085920N)
This publication has 26 references indexed in Scilit:
- Powershap: A Power-Full Shapley Feature Selection Method2023
- Deep compartment models: A deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modelingCPT: Pharmacometrics & Systems Pharmacology, 2022
- Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#Intensive Care Medicine, 2020
- Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017JAMA, 2020
- Personalized antibiotic dosing for the critically illIntensive Care Medicine, 2019
- Augmented Renal Clearance in Critically Ill Patients: A Systematic ReviewClinical Pharmacokinetics, 2018
- Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistanceIntensive Care Medicine, 2017
- ADVAN-style analytical solutions for common pharmacokinetic modelsJournal of Pharmacological and Toxicological Methods, 2015
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsThe Lancet Infectious Diseases, 2014
- Fundamentals of Population Pharmacokinetic ModellingClinical Pharmacokinetics, 2012